A method of predicting PROGRESSION abdominal obesity patients with metabolic syndrome

摘要

method u043fu0440u043eu0433u043du043eu0437u0438u0440u043eu0432u0430u043du0438u00a0 u043fu0440u043eu0433u0440u0435u0441u0441u0438u0440u043eu0432u0430u043du0438u00a0 abdominal u043eu0436u0438u0440u0435u043du0438u00a0 in patients with metabolic syndrome, u0437u0430u043au043bu044eu0447u0430u044eu0449u0438u0439u0441u00a0 is that the patient's blood u043eu043fu0440u0435u0434u0435u043bu00a0u044eu0442; u0435u043du044c with - u043fu0435u043fu0442u0438u0434u0430, with its size of more than 3.5 ng / ml of predicting the progression of abdominal u043eu0436u0438u0440u0435u043du0438u00a0.